Relationships Between Concentrations of Tumor Necrosis Factor-α and Nitric Oxide in Follicular Fluid and Oocyte Quality
Follicular fluid nitric oxide levels were higher in endometriosis and hydrosalpinx patients, while TNF-α concentration was linked to poor oocyte quality, though no correlation existed between NO and TNF-α.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The study measured tumor necrosis factor-α (TNF-α) and nitric oxide (NO) concentrations in 115 follicular fluid samples from 43 women undergoing IVF-ET, and analyzed correlations with oocyte quality and maturity as well as infertility-associated diseases, including endometriosis and hydrosalpinx. The authors found no correlation between NO and TNF-α, and NO levels were significantly higher in patients with endometriosis or hydrosalpinx compared with tubal obstruction alone, while NO did not differ by oocyte maturity or quality. In contrast, TNF-α was significantly higher in poor-quality oocytes, but TNF-α was not associated with infertility-associated diseases (including endometriosis or hydrosalpinx) or with oocyte maturity. The paper reports no significant differences in follicular NO/TNF-α between pregnant and nonpregnant IVF-ET groups, which is a limitation for linking these biomarkers to implantation or pregnancy outcomes. This paper is centrally about endometriosis/hydrosalpinx-related alterations in follicular fluid NO concentrations, with endometriosis explicitly compared as an infertility-associated disease.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
7,561 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Methods
Results
Conclusions
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Elevated levels of interleukin-6 in the follicular fluid at the time of oocyte retrieval for in vitro fertilization may predict the development of early-form ovarian hyperstimulation syndrome via openalex
- W1929009802 via openalex
- W1990802251 via openalex
- W2002503549 via openalex
- W2009184207 via openalex
- W2011150705 via openalex
- W2024650410 via openalex
- W2032172049 via openalex
- W2052816920 via openalex
- W2087435915 via openalex
- W2097909038 via openalex
- W2104993539 via openalex
- W2107111331 via openalex
- W2114500397 via openalex
- W2121852257 via openalex
- W2122867725 via openalex
- W2139701619 via openalex
- W2144800866 via openalex
- W2154471869 via openalex
- W2164319707 via openalex
- W2165807386 via openalex
- W2173833672 via openalex
- W2280643196 via openalex
- W2344494659 via openalex
- W2401512102 via openalex
- W2412023621 via openalex
- W49774080 via openalex
- W2419091818 via openalex
Cited by (24)
- Nanomicelle curcumin improves oxidative stress, inflammatory markers, and assisted reproductive techniques outcomes in endometriosis cases: a randomized clinical trial 2025
- Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial 2023
- Diminished Ovarian Reserve in Endometriosis: Insights from In Vitro, In Vivo, and Human Studies-A Systematic Review 2023
- Novel therapeutic targets to improve IVF outcomes in endometriosis patients: a review and future prospects 2021
- A cross-sectional study on the correlation between cytokines in a pelvic environment and tubal factor infertility 2020
- In Vitro Fertilization, Levels of Pro-Inflammatory Factors and Lipid Peroxidation. 2015
- A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis 2014
- Alteration in the intrafollicular thiol–redox system in infertile women with endometriosis 2014
- Possible effects of endometriosis-related immune events on reproductive function 2013
- Preoperative Serum Anti-Mullerian Hormone Level in Women with Ovarian Endometrioma and Mature Cystic Teratoma 2013
- Pathophysiological factors and genetic association in endometriosis 2011
- IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone 2009
- The role of the oxidative-stress in the endometriosis-related infertility 2009
- SIGNIFICANCE OF OXIDATIVE STRESS IN HUMAN REPRODUCTION 2009
- Endometriosis and ovarian reserve : Inflammation and prognostic markers 2008
- Increased ENA‐78 in the follicular fluid of patients with endometriosis 2006
- Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? 2006
- Nuclear Factor-κB (NF-κB): An Unsuspected Major Culprit in the Pathogenesis of Endometriosis That Is Still at Large? 2006
- Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model 2005
- Endometriosis and Inflammation in Infertility 2004
- Endometriosis and Inflammation in Infertility 2004
- Immunology of Endometriosis and Immunotherapy 2003
- New advances in the understanding of endometriosis related infertility 2002
- Endometriosis is sustained by tumour necrosis factor-α 2002
Source provenance
- europepmc
- last seen: 2026-08-31T06:09:41.840111+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:13:36.046895+00:00